临床药师参与慢性阻塞性肺疾病合并糖尿病的抗感染治疗及药学监护
|
摘要
目的:探讨临床药师在参与慢性阻塞性肺疾病合并糖尿病患者抗感染治疗中的作用。方法:介绍临床药师参与1例慢性阻塞性肺疾病合并糖尿病患者的抗感染治疗经过。结果:临床药师考虑到患者高龄合并糖尿病和免疫系统疾病,并依据患者症状、体征及病原学检测等实验室检查结果,调整抗感染治疗方案,并从药品不良反应、输液速度及药物相互作用等方面对患者实施了药学监护。结论:临床药师发挥专业优势,参与感染性疾病治疗方案的调整,可促进临床用药安全、有效,体现临床药师的职业价值。
OBJECTIVE:To probe into the role of clinic pharmacists in anti-infection therapy in treatment of patients with chronic obstructive pulmonary disease combined with diabetes.METHODS:To introduce the treatment process of anti-infection therapy in treatment of one patient with chronic obstructive pulmonary disease and diabetes participated by clinical pharmacists.RESULTS:In view of the elderly patient had diabetes combined with immune system diseases,according to the patient's symptoms,signs and pathogen detection and some other laboratory test results,the clinical pharmacists adjusted anti-infection therapy scheme and provided pharmaceutical care through the adverse drug reactions,infusion speed and drug interactions,etc.CONCLUSIONS:The clinical pharmacists bring their pharmaceutical specialty into full play through participating in the adjustment of anti-infection therapy scheme,which can promote the safe and effective medication in clinic and reflect the professional value of the clinical pharmacists.
OBJECTIVE:To probe into the role of clinic pharmacists in anti-infection therapy in treatment of patients with chronic obstructive pulmonary disease combined with diabetes.METHODS:To introduce the treatment process of anti-infection therapy in treatment of one patient with chronic obstructive pulmonary disease and diabetes participated by clinical pharmacists.RESULTS:In view of the elderly patient had diabetes combined with immune system diseases,according to the patient's symptoms,signs and pathogen detection and some other laboratory test results,the clinical pharmacists adjusted anti-infection therapy scheme and provided pharmaceutical care through the adverse drug reactions,infusion speed and drug interactions,etc.CONCLUSIONS:The clinical pharmacists bring their pharmaceutical specialty into full play through participating in the adjustment of anti-infection therapy scheme,which can promote the safe and effective medication in clinic and reflect the professional value of the clinical pharmacists.
引文
[1]张连生,姚惠亚,伍进.糖尿病合并慢性阻塞性肺疾病急性发作病原学分析[J].现代实用医学,2010,22(8):881-883.
[2]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南:2013年修订版[J].中华结核和呼吸杂志,2013,36(4):1-10.
[3]周庆涛,贺蓓.慢性阻塞性肺病急性加重期的抗菌药物应用[J].中国药物应用与监测,2011,8(2):65-68.
[4]产超广谱β-内酰胺酶细菌感染防治专家委员会.产超广谱β-内酰胺酶细菌感染防治专家共识[J].中华实验和临床感染病杂志:电子版,2010,4(2):207-214.
[5]马立萍,赵磊,杨京华,等.2型糖尿病合并慢性阻塞性肺疾病急性加重期血糖控制与预后的关系[J].心肺血管病杂志,2012,31(2):189-191.
[6]陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:65-69.
[7]杨烁,邢颖,甄健存.1例慢性阻塞性肺疾病急性加重期合并多种老年病患者的药学监护[J].中国药业,2014,23(1):57-58.
[8]侯宁.氨基糖苷类抗菌药物及其临床应用评价[J].中国医院用药评价与分析,2014,14(8):683-686.
[9]曹娅,刘俊.50例痰热清注射液不良反应及相关因素分析[J].吉林医学,2014,35(1):42-44.
[10]曾焕文,陈大奎,陈静.痰热清注射液与临床113种药物的配伍实验[J].中国医药导报,2011,8(12):189-190.
[11]王红梅.对1例支气管扩张合并心衰患者的用药分析和药学服务[J].中国医院用药评价与分析,2014,14(5):459-462.
[12]李晓兰.临床药师参与1例支气管扩张合并慢性阻塞性肺疾病患者治疗的分析[J].中国医院用药评价与分析,2014,14(8):760-762.
[13]刘瑞琪.慢性阻塞性肺病急性发作合并糖尿病的临床分析[J].安徽医学,2012,33(4):467-468.
[2]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南:2013年修订版[J].中华结核和呼吸杂志,2013,36(4):1-10.
[3]周庆涛,贺蓓.慢性阻塞性肺病急性加重期的抗菌药物应用[J].中国药物应用与监测,2011,8(2):65-68.
[4]产超广谱β-内酰胺酶细菌感染防治专家委员会.产超广谱β-内酰胺酶细菌感染防治专家共识[J].中华实验和临床感染病杂志:电子版,2010,4(2):207-214.
[5]马立萍,赵磊,杨京华,等.2型糖尿病合并慢性阻塞性肺疾病急性加重期血糖控制与预后的关系[J].心肺血管病杂志,2012,31(2):189-191.
[6]陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:65-69.
[7]杨烁,邢颖,甄健存.1例慢性阻塞性肺疾病急性加重期合并多种老年病患者的药学监护[J].中国药业,2014,23(1):57-58.
[8]侯宁.氨基糖苷类抗菌药物及其临床应用评价[J].中国医院用药评价与分析,2014,14(8):683-686.
[9]曹娅,刘俊.50例痰热清注射液不良反应及相关因素分析[J].吉林医学,2014,35(1):42-44.
[10]曾焕文,陈大奎,陈静.痰热清注射液与临床113种药物的配伍实验[J].中国医药导报,2011,8(12):189-190.
[11]王红梅.对1例支气管扩张合并心衰患者的用药分析和药学服务[J].中国医院用药评价与分析,2014,14(5):459-462.
[12]李晓兰.临床药师参与1例支气管扩张合并慢性阻塞性肺疾病患者治疗的分析[J].中国医院用药评价与分析,2014,14(8):760-762.
[13]刘瑞琪.慢性阻塞性肺病急性发作合并糖尿病的临床分析[J].安徽医学,2012,33(4):467-468.